Engages in developing, producing and selling pharmaceutical and chemical products

Lek Pharmaceuticals dd, a subsidiary of Novartis AG, is a company headquartered in Ljubljana, Slovenia, that develops, manufactures and markets drugs and pharmaceutical products. Robert Ljoljo is the CEO, in this role since 2019. On November 21, 2002 Novartis AG acquired Lek Pharmaceuticals dd for $689.24 million.

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

The Group's principal activity is to produce pharmaceuticals and chemicals. The operations are carried out through the following divisions: Pharmaceuticals; Bio chemical; Chemicals; Food and Other. Pharmaceuticals include ethical drugs, bulk pharmaceuticals and biological research. Bio chemicals deal with biochemical diagnostic reagents, animal health products, agrochemicals and fertilizers. Chemicals includes solvents, plasticizes and their raw materials, detergent raw materials and specialty chemicals. Food includes alcoholic beverages, alcohol, seasonings, confectionery, baking ingredients and processed foods. Others include wholesale, commodity distribution and installation of facilities.

Part of GSK Plc, Beecham Group Plc is a British company located in Middlesex. The firm functions as an investment holding company. It was founded in 1928.\nThe company says this about itself: The principal activity Of the Company is the holding of Intercompany bans and receipt Of interest. The Company had previously been an investment holding company. The Company is a member Of the GlaxoSmithKline Group (the 'Group\"). The directors do not envisage any change to the nature of the business in the future,

BGN Tech LLC is an American joint venture company located in Rancho Santa Margarita, CA, that provides research and development services.

Symrise GmbH & Co. KG develops and produces flavors, fragrances, cosmetic ingredients and aroma chemicals. It supplies cosmetic raw materials and active ingredients to the international fragrance, cosmetics and food industry. It's core competencies are extraction and distillation-separation techniques used to isolate natural flavor components. With its new ayurveda Extrapone product range, it offers components from traditional ayurvedic plants and herbs such as sandalwood, lotus flower, cinnamon, ginger and neem. Founded in 2003, the company is headquartered in Holzminden, Germany.

Shanghai Laiyi Biological Drug Research and Development Center Co., Ltd., established on 2001-12-03, The scope of business includes the research of biopharmaceuticals,Technical services in development and related fields,technology development,technical consulting,technology transfer. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Sankyo Co., Ltd. engages in the manufacture and sale of pachinko and pachislot machines. It operates through the following segments: Pachinko Machines Business, Pachislot Machines Business, Ball Bearing Supply Systems Business, and Others. The Pachinko Machines Business segment produces and sells pachinko machines, machine gauges and its related parts. The Pachislot Machines Business segment markets pachislot machines and related parts. The Ball Bearing Supply Systems segment sells pachinko and pachislot ball feeders, card system equipment, and parlor-related equipment. The Others segment comprises of mobile content service, real estate, golf club operations, and sells general molding products. The company was established on April 12, 1966 and is headquartered in Tokyo, Japan.

Zhejiang Pharmaceutical Co., Ltd. Xinchang Pharmaceutical Factory, established on 1999-02-13, Business scope includes licensed projects:pharmaceutical production;Drug Wholesale;food production;food business;Hazardous Chemical Production;Food additive production;Feed additive production;road freight transport(Does not contain dangerous goods);road freight transport(Contains dangerous goods)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Feed Additive Sales;Chemical product sales(No licensed chemical products)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).(Engage in business activities within the business scope of the head office)

Hospira was an American global pharmaceutical and medical device company with headquarters in Lake Forest, Illinois. It had approximately 19,000 employees. Before its acquisition by Pfizer, Hospira was the world's largest producer of generic injectable pharmaceuticals, manufacturing generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems. Hospira's products are used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. It was formerly the hospital products division of Abbott Laboratories. On September 3, 2015, Hospira was acquired by Pfizer, who subsequently sold off the medical devices portion of Hospira to ICU Medical.

Kyowa Hakko Bio Co. Ltd. engages in the manufacture and sale of amino acids and nucleic acids for pharmaceutical and industrial use. The company was founded on October 1, 2008 and is headquartered in Tokyo, Japan.

Lesaffre acts as a global key player in yeasts and fermentation. Lesaffre designs manufactures and markets innovative solutions for baking, food taste & pleasure, health care and biotechnology. The family group born in northern France in 1853, now a multi-national and a multicultural company, Lesaffre is committed to working with confidence to better nourish and protect the planet. In close collaboration with its clients and partners, Lesaffre employs 9,500 people in more than 70 subsidiaries, based in about 40 countries.

Sanofi is a global healthcare company. Among their duties are researching disease causes, determining starting points for drug treatment, developing drugs, producing active ingredients, and delivering finished drugs and active ingredients. Specialists in vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare.

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Novozymes is a world leader in bioinnovation. Novozymes works with its partners to innovate new solutions and rethink industries around the world. Novozymes' industrial enzymes, microorganisms, biopolymers, and other proteins allow its customers to achieve more efficient use of raw materials, reduce energy consumption, replace traditional chemicals with more sustainable alternatives, and offer higher-quality products. Novozymes rethinks everyday products every day.

Meiji Seika Pharma Co., Ltd. engages in the business of manufacture and distribution of pharmaceutical products. It also engages in the animal health business. The company was founded on October 9, 1916 and is headquartered in Tokyo, Japan.

Shaanxi Haisifu Biological Engineering Co., Ltd., established on 2014-04-10, Business scope includes general items:Plant Extracted Pharmaceutical Raw Materials,Pharmaceutical Intermediates,Research and development of microcapsule powder,Production,Sales;Edible oil and its products,Food and Food Additives,R&D of solid beverage,Production,Sales;Research and development of cosmetic raw materials,Production,Sales;Chemical Products(Excluding hazardous chemicals),Research and development of agricultural and sideline products,Production,Sales;Research and development of feed and feed additives,Production,Sales;Import and export business of goods and technology(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).